Study design and population
This is a retrospective chart review pilot study based on a 1-year (2018) analysis of longitudinal structured data collected into the electronic health record (EHR) database of a cohort of patients evaluated at Lifedoc Health in Memphis, Tennessee, USA. Of the 1,113 adult patients seen in 2018, the final sample included 598 subjects (58.9% African American, 35.3%, Hispanic and 5.9% Caucasians) meeting the appropriate inclusion criteria, namely ≥ 18 years of age with BMI and blood pressure (BP) measurements recorded in at least Q1 and Q4, and having any of the following risk factors to activate the MDT protocol: (1) overweight (OW)/obesity (OB) (ICD-10 diagnosis or BMI ≥ 25), (2) hypertension (HTN) (ICD-10 diagnosis, SBP ≥ 140 or DBP ≥90 mmHg), or (3) pre-diabetes (Pre-DM)/diabetes (DM) (ICD-10 diagnoses or glycated hemoglobin A1C (A1C) ≥ 5.6% and 6.5%, respectively). Prior to data collection, informed consent was obtained from each patient. All procedures were performed in accordance with the Helsinki Declaration.